Market Pulse LIVECAST Terminal Movers Brief Politics Macro Calendar

More

Stocks About Why SquawkNews Newsroom Schedule Prediction Markets Disclosure Wire Crypto Search

Market Pulse LIVECAST

Menu

Home Market Pulse LIVECAST Terminal Movers Brief Politics Macro Calendar Stocks About Why SquawkNews Newsroom Schedule Prediction Markets Disclosure Wire Crypto Search

Live News EQUITY L impact Jul 22, 2026, 10:44 AM UTC

US MARKET FUTURES

US MARKET FUTURES

SquawkNews Newsroom

US MARKET FUTURES

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

BEP +2% BEPC - PR last night: Brookfield Renewable Partners And Brookfield Renewable Approve Plans To Simplify Its Corporate Structure By Co BEP +2% BEPC - PR last night: Brookfield Renewable Partners And Brookfield Renewable Approve Plans To Simplify Its Corporate Structure By Converting BEP And BEPC Into One Publicly L impact | EQUITY | Jul 22, 2026, 12:45 PM UTC KAPA BAYRY kairos Pharma announces strategic collaboration with Bayer to enhance xofigo activity in metastatic prostate cancer Kairos Pharma KAPA BAYRY kairos Pharma announces strategic collaboration with Bayer to enhance xofigo activity in metastatic prostate cancer Kairos Pharma: to evaluate Co's lead antibody env-105 L impact | EQUITY | Jul 22, 2026, 12:44 PM UTC AMZN Q2 Preview: Raising Q2 AWS, expect Q3 guide to bracket Street on Prime Day comp; Reiterate Buy @ BAML AMZN Q2 Preview: Raising Q2 AWS, expect Q3 guide to bracket Street on Prime Day comp; Reiterate Buy @ BAML L impact | EQUITY | Jul 22, 2026, 12:42 PM UTC SMCI PT raised from $40 to $46, maintains Buy @ Needham SMCI PT raised from $40 to $46, maintains Buy @ Needham L impact | EQUITY | Jul 22, 2026, 12:42 PM UTC SMMT +1.85% in pre-mkt trading - earlier PR: Ivonescimab Plus Chemotherapy Shows Consistent, Favorable Overall Survival Results in Western a SMMT +1.85% in pre-mkt trading - earlier PR: Ivonescimab Plus Chemotherapy Shows Consistent, Favorable Overall Survival Results in Western and Asian Patients in Updated Analysis fr L impact | EQUITY | Jul 22, 2026, 12:42 PM UTC RBLX Raise PT to $54 - Q226 Preview: green shoots seen, but age-up thesis remains unproven; Reit Neutral @ BAML RBLX Raise PT to $54 - Q226 Preview: green shoots seen, but age-up thesis remains unproven; Reit Neutral @ BAML L impact | EQUITY | Jul 22, 2026, 12:41 PM UTC

SQUAWK/NEWS

Real-time financial news agency. Market-moving headlines, macro, politics, filings and audio squawk built for traders.

Pro plan coming — join the list.

Product

LiveCast
Terminal
Brief
Macro
Calendar
Search

For Traders

Market Movers
News for Traders
How to Trade News
What Is a Squawk
Market Pulse
Disclosure Wire

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews robots / sitemap SquawkNews publishes factual market information and context. It is not investment advice and does not provide trade recommendations.

We use analytics (GA4, Clarity, PostHog) to improve the product. Privacy Policy